Apple Watch Blood Pressure Notification Feature Under FDA Review — Could Debut at WWDC Next Week

Apple's long-rumored blood pressure monitoring feature is closer than ever. According to 9to5Mac, a new high blood pressure notification is currently under FDA review and is "almost certainly" coming to watchOS 27, which Apple will preview at WWDC on June 8.

How It Will Work

• Trend-based monitoring: The feature will track blood pressure patterns over time rather than providing exact systolic/diastolic readings like a doctor's cuff
• Nighttime tracking likely: Similar to the Oura Ring 5's approach, Apple may focus on sleep-time measurements when the cardiovascular system is most stable
• Notification-based alerts: Users would be notified if their blood pressure trends upward over time — an early warning system for hypertension
• FDA clearance required: The feature cannot ship without FDA approval, which is currently pending

watchOS 27 at WWDC

Blood pressure is one of three major watchOS 27 features expected at WWDC, alongside improved heart rate tracking and new watch faces including a simplified Modular Ultra variant for non-Ultra models. The overall focus is on stability and AI-powered health refinements.

What This Means for Buyers

If you're debating between buying an Apple Watch Series 11 now at $259 or waiting for Series 12 this fall, blood pressure monitoring could tip the decision. However, the feature depends on FDA timing — it may launch with Series 12 or be delayed to a later software update. If blood pressure is your priority today, the Oura Ring 5 already includes it. Compare all options in our smartwatch guide.